このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Lincoln Pharmaceuticals 配当金
配当金 基準チェック /56
Lincoln Pharmaceuticals配当を支払う会社であり、現在の利回りは0.29%で、収益によって十分にカバーされています。
主要情報
0.3%
配当利回り
4%
配当性向
| 業界平均利回り | 0.8% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | n/a |
| 一株当たり利益 | ₹46.58 |
| 3年後の配当利回り予想 | n/a |
最近の配当金アップデート
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 14
Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50
Aug 31Recent updates
Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Business And Shares Still Trailing The Market
Mar 14Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?
Nov 04Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 14Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50
Aug 31Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 12Lincoln Pharmaceuticals (NSE:LINCOLN) Is Due To Pay A Dividend Of ₹1.50
Aug 29If You Like EPS Growth Then Check Out Lincoln Pharmaceuticals (NSE:LINCOLN) Before It's Too Late
Feb 14Should You Be Adding Lincoln Pharmaceuticals (NSE:LINCOLN) To Your Watchlist Today?
Aug 16Here's Why I Think Lincoln Pharmaceuticals (NSE:LINCOLN) Is An Interesting Stock
May 06Is Lincoln Pharmaceuticals Limited (NSE:LINCOLN) A Smart Choice For Dividend Investors?
Apr 03Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?
Mar 15Could The Market Be Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Given Its Attractive Financial Prospects?
Feb 28Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares
Feb 12Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?
Feb 01
Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 27% Gain In The Last Five Years
Jan 19Trade Alert: The Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Munjal Patel, Has Just Spent ₹20m Buying 9.2% More Shares
Jan 06Why Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Is A Dividend Rockstar
Dec 27Lincoln Pharmaceuticals's (NSE:LINCOLN) Earnings Are Growing But Is There More To The Story?
Dec 14Have Insiders Been Buying Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Shares This Year?
Dec 01Declining Stock and Solid Fundamentals: Is The Market Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN)?
Nov 18Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?
Nov 05Is Now The Time To Put Lincoln Pharmaceuticals (NSE:LINCOLN) On Your Watchlist?
Oct 23Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 74% Gain In The Last Year
Oct 05Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Vies For A Place In Your Dividend Portfolio: Here's Why
Sep 18決済の安定と成長
配当データの取得
安定した配当: LINCOLNの1株当たり配当金は過去10年間安定しています。
増加する配当: LINCOLNの配当金は過去10年間にわたって増加しています。
配当利回り対市場
| Lincoln Pharmaceuticals 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (LINCOLN) | 0.3% |
| 市場下位25% (IN) | 0.3% |
| 市場トップ25% (IN) | 1.1% |
| 業界平均 (Pharmaceuticals) | 0.8% |
| 3年後のアナリスト予想 (LINCOLN) | n/a |
注目すべき配当: LINCOLNの配当金 ( 0.29% ) はIndian市場の配当金支払者の下位 25% ( 0.27% ) よりも高くなっています。
高配当: LINCOLNの配当金 ( 0.29% ) はIndian市場の配当金支払者の上位 25% ( 1.16% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: LINCOLNの配当性向は低く ( 3.9% )、配当金は利益によって十分にカバーされています。
株主配当金
キャッシュフローカバレッジ: LINCOLNは低い 現金配当性向 ( 15.3% ) であるため、配当金の支払いはキャッシュフローによって十分にカバーされています。